| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.0002 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0005 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.005 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.005 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.008 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |